-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Cdwb2t+yeoQwDgv5ttdDiNLOXyl93Gk3Y2IlxNGkwSfowQqPAwpGS/hLy9FWwxs4 U0JIYR67S7+C1UbOD6W2Bg== 0001209191-05-018105.txt : 20050331 0001209191-05-018105.hdr.sgml : 20050331 20050331103338 ACCESSION NUMBER: 0001209191-05-018105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050330 FILED AS OF DATE: 20050331 DATE AS OF CHANGE: 20050331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILMARTIN RAYMOND V CENTRAL INDEX KEY: 0001181176 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03305 FILM NUMBER: 05716962 BUSINESS ADDRESS: STREET 1: MERCK & CO INC STREET 2: ONE MERCK DR PO BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889 BUSINESS PHONE: 9084231000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERCK & CO INC CENTRAL INDEX KEY: 0000064978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221109110 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MERCK DR STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 9084234044 MAIL ADDRESS: STREET 1: ONE MERCK DR STREET 2: PO BOX 100 WS3AB-05 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-03-30 0 0000064978 MERCK & CO INC (MRK) 0001181176 GILMARTIN RAYMOND V ONE MERCK DRIVE P.O. BOX 100 WHITEHOUSE STATION NJ 08889-0100 1 1 0 0 COB, President, CEO Phantom Stock 2005-03-30 4 A 0 1644.0814 32.44 A Common Stock 1644.0814 131530.4997 D 1-for-1 The Merck Deferral Program includes the right of redesignation to other investment measures within the Program. Distributions of phantom stock are made in shares of Merck Common Stock, with cash payable for partial shares, in accordance with a distribution schedule elected by the reporting person. This distribution is subject to conditions and limitations of the Merck Deferral Program. Holdings include shares acquired in dividend reinvestment transactions. Debra A. Bollwage as Attorney-in-Fact for Raymond V. Gilmartin 2005-03-31 -----END PRIVACY-ENHANCED MESSAGE-----